Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» guidance
guidance
What to Expect for AstraZeneca in Fiscal 2018
Market Realist
Sat, 06/9/18 - 10:11 am
AstraZeneca
guidance
generics
Crestor
Japan
Europe
Medtronic releases long term guidance
Mass Device
Tue, 06/5/18 - 12:03 pm
Medtronic
devices
guidance
earnings
By How Much Did Eli Lilly Revise Guidance for 2016?
Market Realist
Mon, 08/8/16 - 09:55 am
Eli Lilly
earnings
guidance
Allergan Raises Profit Forecast as Valeant Pursues Bid
Bloomberg
Thu, 10/9/14 - 08:45 am
Allergan
Valeant Pharmaceuticals
guidance
AbbVie Raises Outlook on Strong Performance Amid Shire Offer
Bloomberg
Mon, 06/23/14 - 09:41 am
AbbVie
Shire
M&A
guidance
Bayer Raises Drug Sales Forecast as Quarterly Profit Lags
Bloomberg
Fri, 02/28/14 - 08:30 am
Bayer
guidance
earnings
Merck Raises 2013 Profit Forecast on Speed of Cost Cuts
Bloomberg
Thu, 11/14/13 - 12:10 pm
Merck
guidance
Sanofi Profit Forecast Eases Concern After Setbacks
Bloomberg
Wed, 10/30/13 - 09:42 am
Sanofi
guidance
Novartis Raises 2013 Forecast on Lack of Diovan Generic
Bloomberg
Tue, 10/22/13 - 08:11 am
Novartis
guidance
Diovan
Johnson & Johnson expect to incur $100M charge to net income in Q1
The Fly on the Wall
Mon, 02/25/13 - 09:48 am
JNJ
guidance
Strong 1Q from Myriad, Guidance Up
Yahoo/Zacks.com
Tue, 11/6/12 - 04:24 pm
earnings
guidance
Myriad Genetics
Novo hikes forecast on 62% jump in Victoza sales
Fierce Pharma
Wed, 10/31/12 - 11:14 am
Novo Nordisk
guidance
Novo raises targets on Victoza, insulin demand
Yahoo/Reuters
Thu, 08/9/12 - 11:35 am
Victoza
guidance
Novo Nordisk
insulin
Lilly raises 2012 net profit forecast
Reuters
Thu, 08/9/12 - 10:59 am
Lilly
guidance
Actelion Raises 2012 Forecast On Reduced First-Half Costs
Bloomberg
Thu, 07/19/12 - 07:45 am
Actelion
guidance
PDL BioPharma expects 2 percent revenue growth on better sales of Herceptin, Lucentis, Tysabri
Yahoo/AP
Thu, 06/14/12 - 01:22 pm
PDL Biopharma
guidance
Herceptin
Biogen Idec
Lucentis
Tysabri
Forest Labs cuts outlook on Lexapro discounts
Yahoo/AP
Mon, 06/11/12 - 01:08 pm
Forest Labs
Lexapro
guidance
Teva Issues 2012 Outlook
Yahoo/Zacks
Tue, 05/29/12 - 11:12 am
Teva Pharmaceuticals
guidance
Teva Pharm cuts 2012 sales, profit outlook
Reuters
Thu, 05/24/12 - 10:13 am
Teva Pharmaceuticals
guidance
Warner Chilcott cuts full-year forecast
Reuters
Fri, 05/4/12 - 10:44 am
earnings
guidance
Warner Chilcott
Pages
1
2
3
4
next ›
last »